{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Opioid use and Risks in Candidates and Recipients of Liver Transplant
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- Define the prevalence, patterns, and impact of opioid use and misuse in patients with chronic liver disease.
- Describe the connections between pre-liver transplant opioid use and post-transplant opioid use and how these features impact patient outcomes.
- Explain the risks associated with polysubstance use in patients with chronic liver disease.
- Discuss how to apply screening techniques for high-risk opioid use in patients with chronic liver disease and how to employ safe opioid prescribing strategies in patients with chronic liver disease and in liver transplant recipients.
Disclosures
Elizabeth S. Aby owns stock in United Health Group and Medtronic. The remaining authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity.
Price:
$30.00
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: LVT0225B
Published: February 2025
Expires: 1/31/2027
Sources:
Liver Transplantation
Required Passing Score: 4/5 (80%)
Categories:
Hepatology
Specialties:
Hepatology,
Internal Medicine